Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1

Br J Dermatol. 2024 Jan 23;190(2):145-146. doi: 10.1093/bjd/ljad452.

Authors

Carlos G Romo¹, Kavita Y Sarin², Jaishri O Blakeley¹

Affiliations

¹ Department of Neurology, Johns Hopkins University, Baltimore, MD.
² Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.

PMID: 38123358
DOI: 10.1093/bjd/ljad452

No abstract available

Publication types

Editorial
Comment

MeSH terms

Genome-Wide Association Study
Humans
Neurofibroma* / complications
Neurofibroma* / genetics
Neurofibromatosis 1* / genetics
Risk Assessment
Skin Neoplasms* / genetics